ANAGENICS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.01 AUD | +11.11% |
|
+11.11% | -47.37% |
| Mar. 08 | Anagenics Appoints CEO | MT |
| Feb. 26 | Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Anagenics Limited is an Australia-based health and beauty-tech company. The Company offers a range of clinically validated anti-ageing and wellness products developed in-house or sourced from premium international brands. The Company, through its wholly owned subsidiary Advangen Pty Ltd, develops, manufactures and markets anti-aging products globally, with its FGF5 inhibitor hair health and hair growth products sold worldwide. The flagship anti-aging hair care range, marketed as evolis, Advangen Jo-Ju and Lexilis brands, is sold in Japan, the United States of America and Australia. The Companyâs subsidiary is BLC Cosmetics Pty Limited, which is the distributor of international and local skin care and wellbeing brands.
Sector
Personal Products
Calendar
2024-08-27
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -47.37% | 2.71M | |
| +10.32% | 381B | |
| +8.03% | 129B | |
| -16.39% | 62.59B | |
| +0.37% | 52.86B | |
| -11.47% | 36.11B | |
| +2.76% | 33.57B | |
| +9.68% | 17.29B | |
| +7.68% | 14.75B | |
| -9.06% | 10.82B |
- Stock Market
- Equities
- AN1 Stock
- News Anagenics Limited
- Anagenics Raises Funds from Institutional Entitlement Offer
